ClinicalTrials.gov
public full text
Public Domain
A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
The purpose of this research study is to compare the effects (good and bad) on subjects and their cancer using standard chemotherapy in combination with hypofractionated proton radiation therapy. Hypofractionation is a technique that delivers higher daily doses of radiation over a shorter period of time.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prostate Cancer - Localized Adenocarcinoma Proton Therapy#1153125
- Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma#1115010
- Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer#1113928
- Hypofractionated Chemoradiotherapy for Cervical Cancer#897302
- Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer#995459
Record · ID 897366
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive